CompletedPhase 1NCT01661400

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors

Studying Glial tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
Andrew Cluster, M.D., MD
Washington University School of Medicine
Intervention
Metronomic Cyclophosphamide(drug)
Enrollment
14 enrolled
Eligibility
21 years · All sexes
Timeline
2012 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01661400 on ClinicalTrials.gov

Other trials for Glial tumor

Additional recruiting or active studies for the same condition.

See all trials for Glial tumor →

← Back to all trials